Skip to Navigation Skip to Search Skip to Content
Search All Centers

Bob Azopardi: My Clinical Trial Experience

Published on April 25, 2016

Patient Power Founder, Andrew Schorr, interviewed Bob Azopardi, a 16-year CLL patient who participated in the Phase III arm of the venetoclax (Venclexta) clinical trial.  Bob discusses his involvement on the trial including the many safety precautions in place for patients and the new quality of life he experiences.

Featuring

You might also like